[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2026

August 2020 | 119 pages | ID: C33B1D07DCF8EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SPECT Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global SPECT Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the SPECT Radiopharmaceuticals market is segmented into
  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Indium-111
  • Other
Segment by Application, the SPECT Radiopharmaceuticals market is segmented into
  • Oncology
  • Cardiology
  • Thyroid
Regional and Country-level Analysis
The SPECT Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).

The key regions covered in the SPECT Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and SPECT Radiopharmaceuticals Market Share Analysis
SPECT Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in SPECT Radiopharmaceuticals business, the date to enter into the SPECT Radiopharmaceuticals market, SPECT Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
  • GE Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bracco Imaging
  • Eczacibasi-Monrol Nuclear Products
  • IBA Molecular Imaging
  • Jubilant Life Sciences
1 STUDY COVERAGE

1.1 SPECT Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key SPECT Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type
  1.4.2 Technetium-99
  1.4.3 Thallium-201
  1.4.4 Gallium-67
  1.4.5 Iodine-123
  1.4.6 Indium-111
  1.4.7 Other
1.5 Market by Application
  1.5.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application
  1.5.2 Oncology
  1.5.3 Cardiology
  1.5.4 Thyroid
1.6 Coronavirus Disease 2019 (Covid-19): SPECT Radiopharmaceuticals Industry Impact
  1.6.1 How the Covid-19 is Affecting the SPECT Radiopharmaceuticals Industry
    1.6.1.1 SPECT Radiopharmaceuticals Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and SPECT Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for SPECT Radiopharmaceuticals Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global SPECT Radiopharmaceuticals Market Size Estimates and Forecasts
  2.1.1 Global SPECT Radiopharmaceuticals Revenue 2015-2026
  2.1.2 Global SPECT Radiopharmaceuticals Sales 2015-2026
2.2 SPECT Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
  2.2.1 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL SPECT RADIOPHARMACEUTICALS COMPETITOR LANDSCAPE BY PLAYERS

3.1 SPECT Radiopharmaceuticals Sales by Manufacturers
  3.1.1 SPECT Radiopharmaceuticals Sales by Manufacturers (2015-2020)
  3.1.2 SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 SPECT Radiopharmaceuticals Revenue by Manufacturers
  3.2.1 SPECT Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
  3.2.2 SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global SPECT Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by SPECT Radiopharmaceuticals Revenue in 2019
  3.2.5 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 SPECT Radiopharmaceuticals Price by Manufacturers
3.4 SPECT Radiopharmaceuticals Manufacturing Base Distribution, Product Types
  3.4.1 SPECT Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers SPECT Radiopharmaceuticals Product Type
  3.4.3 Date of International Manufacturers Enter into SPECT Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global SPECT Radiopharmaceuticals Market Size by Type (2015-2020)
  4.1.1 Global SPECT Radiopharmaceuticals Sales by Type (2015-2020)
  4.1.2 Global SPECT Radiopharmaceuticals Revenue by Type (2015-2020)
  4.1.3 SPECT Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global SPECT Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
  4.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Type (2021-2026)
  4.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
  4.2.3 SPECT Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global SPECT Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global SPECT Radiopharmaceuticals Market Size by Application (2015-2020)
  5.1.1 Global SPECT Radiopharmaceuticals Sales by Application (2015-2020)
  5.1.2 Global SPECT Radiopharmaceuticals Revenue by Application (2015-2020)
  5.1.3 SPECT Radiopharmaceuticals Price by Application (2015-2020)
5.2 SPECT Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
  5.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Application (2021-2026)
  5.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
  5.2.3 Global SPECT Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America SPECT Radiopharmaceuticals by Country
  6.1.1 North America SPECT Radiopharmaceuticals Sales by Country
  6.1.2 North America SPECT Radiopharmaceuticals Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America SPECT Radiopharmaceuticals Market Facts & Figures by Type
6.3 North America SPECT Radiopharmaceuticals Market Facts & Figures by Application

7 EUROPE

7.1 Europe SPECT Radiopharmaceuticals by Country
  7.1.1 Europe SPECT Radiopharmaceuticals Sales by Country
  7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Type
7.3 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific SPECT Radiopharmaceuticals by Region
  8.1.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Region
  8.1.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Type
8.3 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America SPECT Radiopharmaceuticals by Country
  9.1.1 Latin America SPECT Radiopharmaceuticals Sales by Country
  9.1.2 Latin America SPECT Radiopharmaceuticals Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America SPECT Radiopharmaceuticals Market Facts & Figures by Type
9.3 Central & South America SPECT Radiopharmaceuticals Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa SPECT Radiopharmaceuticals by Country
  10.1.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Country
  10.1.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Type
10.3 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 GE Healthcare
  11.1.1 GE Healthcare Corporation Information
  11.1.2 GE Healthcare Description, Business Overview and Total Revenue
  11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
  11.1.5 GE Healthcare Recent Development
11.2 Cardinal Health
  11.2.1 Cardinal Health Corporation Information
  11.2.2 Cardinal Health Description, Business Overview and Total Revenue
  11.2.3 Cardinal Health Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Cardinal Health SPECT Radiopharmaceuticals Products Offered
  11.2.5 Cardinal Health Recent Development
11.3 Lantheus Medical Imaging
  11.3.1 Lantheus Medical Imaging Corporation Information
  11.3.2 Lantheus Medical Imaging Description, Business Overview and Total Revenue
  11.3.3 Lantheus Medical Imaging Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Products Offered
  11.3.5 Lantheus Medical Imaging Recent Development
11.4 Bracco Imaging
  11.4.1 Bracco Imaging Corporation Information
  11.4.2 Bracco Imaging Description, Business Overview and Total Revenue
  11.4.3 Bracco Imaging Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Bracco Imaging SPECT Radiopharmaceuticals Products Offered
  11.4.5 Bracco Imaging Recent Development
11.5 Eczacibasi-Monrol Nuclear Products
  11.5.1 Eczacibasi-Monrol Nuclear Products Corporation Information
  11.5.2 Eczacibasi-Monrol Nuclear Products Description, Business Overview and Total Revenue
  11.5.3 Eczacibasi-Monrol Nuclear Products Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Products Offered
  11.5.5 Eczacibasi-Monrol Nuclear Products Recent Development
11.6 IBA Molecular Imaging
  11.6.1 IBA Molecular Imaging Corporation Information
  11.6.2 IBA Molecular Imaging Description, Business Overview and Total Revenue
  11.6.3 IBA Molecular Imaging Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Products Offered
  11.6.5 IBA Molecular Imaging Recent Development
11.7 Jubilant Life Sciences
  11.7.1 Jubilant Life Sciences Corporation Information
  11.7.2 Jubilant Life Sciences Description, Business Overview and Total Revenue
  11.7.3 Jubilant Life Sciences Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Products Offered
  11.7.5 Jubilant Life Sciences Recent Development
11.1 GE Healthcare
  11.1.1 GE Healthcare Corporation Information
  11.1.2 GE Healthcare Description, Business Overview and Total Revenue
  11.1.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
  11.1.5 GE Healthcare Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 SPECT Radiopharmaceuticals Market Estimates and Projections by Region
  12.1.1 Global SPECT Radiopharmaceuticals Sales Forecast by Regions 2021-2026
  12.1.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
12.2 North America SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
  12.2.1 North America: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
  12.2.2 North America: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
  12.2.3 North America: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.3 Europe SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
  12.3.1 Europe: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
  12.3.2 Europe: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
  12.3.3 Europe: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: SPECT Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
12.5 Latin America SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
  12.5.1 Latin America: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
  12.5.2 Latin America: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
  12.5.3 Latin America: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa SPECT Radiopharmaceuticals Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: SPECT Radiopharmaceuticals Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: SPECT Radiopharmaceuticals Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: SPECT Radiopharmaceuticals Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key SPECT Radiopharmaceuticals Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 SPECT Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. SPECT Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top SPECT Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Technetium-99
Table 5. Major Manufacturers of Thallium-201
Table 6. Major Manufacturers of Gallium-67
Table 7. Major Manufacturers of Iodine-123
Table 8. Major Manufacturers of Indium-111
Table 9. Major Manufacturers of Other
Table 10. COVID-19 Impact Global Market: (Four SPECT Radiopharmaceuticals Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for SPECT Radiopharmaceuticals Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for SPECT Radiopharmaceuticals Players to Combat Covid-19 Impact
Table 15. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Units)
Table 16. Global SPECT Radiopharmaceuticals Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 17. Global SPECT Radiopharmaceuticals Sales by Regions 2015-2020 (K Units)
Table 18. Global SPECT Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 19. Global SPECT Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global SPECT Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Units)
Table 21. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 22. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2019)
Table 24. SPECT Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers SPECT Radiopharmaceuticals Price (2015-2020) (USD/Unit)
Table 27. SPECT Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers SPECT Radiopharmaceuticals Product Type
Table 29. Date of International Manufacturers Enter into SPECT Radiopharmaceuticals Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 32. Global SPECT Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 33. Global SPECT Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 34. Global SPECT Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 35. SPECT Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 36. Global SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 37. Global SPECT Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 38. North America SPECT Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 39. North America SPECT Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 40. North America SPECT Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 41. North America SPECT Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 42. North America SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 43. North America SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 44. North America SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 45. North America SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 46. Europe SPECT Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 47. Europe SPECT Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 48. Europe SPECT Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 50. Europe SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 51. Europe SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 52. Europe SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 53. Europe SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific SPECT Radiopharmaceuticals Sales by Region (2015-2020) (K Units)
Table 55. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific SPECT Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 59. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 61. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 62. Latin America SPECT Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 63. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa SPECT Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 66. Latin America SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 67. Latin America SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 68. Latin America SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 69. Latin America SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa SPECT Radiopharmaceuticals Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa SPECT Radiopharmaceuticals Sales by Type (2015-2020) (K Units)
Table 75. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa SPECT Radiopharmaceuticals Sales by Application (2015-2020) (K Units)
Table 77. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 78. GE Healthcare Corporation Information
Table 79. GE Healthcare Description and Major Businesses
Table 80. GE Healthcare SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. GE Healthcare Product
Table 82. GE Healthcare Recent Development
Table 83. Cardinal Health Corporation Information
Table 84. Cardinal Health Description and Major Businesses
Table 85. Cardinal Health SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Cardinal Health Product
Table 87. Cardinal Health Recent Development
Table 88. Lantheus Medical Imaging Corporation Information
Table 89. Lantheus Medical Imaging Description and Major Businesses
Table 90. Lantheus Medical Imaging SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Lantheus Medical Imaging Product
Table 92. Lantheus Medical Imaging Recent Development
Table 93. Bracco Imaging Corporation Information
Table 94. Bracco Imaging Description and Major Businesses
Table 95. Bracco Imaging SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Bracco Imaging Product
Table 97. Bracco Imaging Recent Development
Table 98. Eczacibasi-Monrol Nuclear Products Corporation Information
Table 99. Eczacibasi-Monrol Nuclear Products Description and Major Businesses
Table 100. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Eczacibasi-Monrol Nuclear Products Product
Table 102. Eczacibasi-Monrol Nuclear Products Recent Development
Table 103. IBA Molecular Imaging Corporation Information
Table 104. IBA Molecular Imaging Description and Major Businesses
Table 105. IBA Molecular Imaging SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. IBA Molecular Imaging Product
Table 107. IBA Molecular Imaging Recent Development
Table 108. Jubilant Life Sciences Corporation Information
Table 109. Jubilant Life Sciences Description and Major Businesses
Table 110. Jubilant Life Sciences SPECT Radiopharmaceuticals Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Jubilant Life Sciences Product
Table 112. Jubilant Life Sciences Recent Development
Table 113. Global SPECT Radiopharmaceuticals Sales Forecast by Regions (2021-2026) (K Units)
Table 114. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Regions (2021-2026)
Table 115. Global SPECT Radiopharmaceuticals Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 116. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Regions (2021-2026)
Table 117. North America: SPECT Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 118. North America: SPECT Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Europe: SPECT Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 120. Europe: SPECT Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Asia Pacific: SPECT Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Units)
Table 122. Asia Pacific: SPECT Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 123. Latin America: SPECT Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 124. Latin America: SPECT Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Middle East and Africa: SPECT Radiopharmaceuticals Sales Forecast by Country (2021-2026) (K Units)
Table 126. Middle East and Africa: SPECT Radiopharmaceuticals Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 128. Key Challenges
Table 129. Market Risks
Table 130. Main Points Interviewed from Key SPECT Radiopharmaceuticals Players
Table 131. SPECT Radiopharmaceuticals Customers List
Table 132. SPECT Radiopharmaceuticals Distributors List
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. SPECT Radiopharmaceuticals Product Picture
Figure 2. Global SPECT Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. Technetium-99 Product Picture
Figure 4. Thallium-201 Product Picture
Figure 5. Gallium-67 Product Picture
Figure 6. Iodine-123 Product Picture
Figure 7. Indium-111 Product Picture
Figure 8. Other Product Picture
Figure 9. Global SPECT Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 10. Oncology
Figure 11. Cardiology
Figure 12. Thyroid
Figure 13. SPECT Radiopharmaceuticals Report Years Considered
Figure 14. Global SPECT Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 15. Global SPECT Radiopharmaceuticals Sales 2015-2026 (K Units)
Figure 16. Global SPECT Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 18. Global SPECT Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 19. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 20. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 21. Global SPECT Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by SPECT Radiopharmaceuticals Revenue in 2019
Figure 23. SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global SPECT Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 25. Global SPECT Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 26. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 27. Global SPECT Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 28. Global SPECT Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 29. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 30. Global SPECT Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 31. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 32. Global SPECT Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 33. North America SPECT Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America SPECT Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America SPECT Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 36. North America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 37. U.S. SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America SPECT Radiopharmaceuticals Market Share by Type in 2019
Figure 42. North America SPECT Radiopharmaceuticals Market Share by Application in 2019
Figure 43. Europe SPECT Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe SPECT Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe SPECT Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 46. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 47. Germany SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 50. France SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe SPECT Radiopharmaceuticals Market Share by Type in 2019
Figure 58. Europe SPECT Radiopharmaceuticals Market Share by Application in 2019
Figure 59. Asia Pacific SPECT Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific SPECT Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 62. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 63. China SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 64. China SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 70. India SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific SPECT Radiopharmaceuticals Market Share by Type in 2019
Figure 86. Asia Pacific SPECT Radiopharmaceuticals Market Share by Application in 2019
Figure 87. Latin America SPECT Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America SPECT Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 90. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 91. Mexico SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America SPECT Radiopharmaceuticals Market Share by Type in 2019
Figure 98. Latin America SPECT Radiopharmaceuticals Market Share by Application in 2019
Figure 99. Middle East and Africa SPECT Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa SPECT Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 102. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 103. Turkey SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E SPECT Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E SPECT Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa SPECT Radiopharmaceuticals Market Share by Type in 2019
Figure 110. Middle East and Africa SPECT Radiopharmaceuticals Market Share by Application in 2019
Figure 111. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Cardinal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Lantheus Medical Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Eczacibasi-Monrol Nuclear Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. IBA Molecular Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Jubilant Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America SPECT Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America SPECT Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe SPECT Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe SPECT Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific SPECT Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific SPECT Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America SPECT Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America SPECT Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa SPECT Radiopharmaceuticals Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa SPECT Radiopharmaceuticals Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed


More Publications